Perceptive Advisors LLC 13D and 13G filings for Landos Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-30 4:44 pm Unchanged |
2023-03-23 | 13D | Landos Biopharma, Inc. LABP |
Perceptive Advisors LLC | 1,486,992 47.700% |
0 (Unchanged) |
Filing |
| 2023-01-13 5:07 pm Unchanged |
2023-01-10 | 13D | Landos Biopharma, Inc. LABP |
Perceptive Advisors LLC | 1,486,992 36.900% |
0 (Unchanged) |
Filing |
| 2022-08-09 09:15 am Sale |
2022-08-09 | 13D | Landos Biopharma, Inc. LABP |
Perceptive Advisors LLC | 1,486,992 36.900% |
-309,092 (-17.21%) |
Filing |
| 2021-04-06 5:00 pm Unchanged |
2021-03-31 | 13D | Landos Biopharma, Inc. LABP |
Perceptive Advisors LLC | 1,796,084 44.800% |
0 (Unchanged) |
Filing |
| 2021-02-18 5:15 pm Purchase |
2021-02-08 | 13D | Landos Biopharma, Inc. LABP |
Perceptive Advisors LLC | 1,796,084 45.900% |
1,796,084 (New Position) |
Filing |